Epredia to distribute Paige Digital Pathology Software globally

Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in ...

March 18, 2021 | Thursday | News
Fujitsu, NCC to create new services for clinical trials, drug development in Japan

Fujitsu has announced it has concluded a comprehensive collaborative research agreement with National Cancer Center Japa...

March 18, 2021 | Thursday | News
Daiichi Sankyo begins manufacture of the AstraZeneca COVID-19 Vaccine in Japan

Daiichi Sankyo Company, Ltd announced on March 12, 2021, that it has started manufacturing the AstraZeneca COVID-19 vacc...

March 17, 2021 | Wednesday | News
Eisai aims for novel drug discovery for neurodegenerative disorders

German firm Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) and Japan based Eisai have announced that b...

March 17, 2021 | Wednesday | News
Takeda, IDT support manufacturing of J&J's COVID-19 vaccine

Takeda Pharmaceutical Company Limited has announced a reciprocal agreement with IDT Biologika GmbH (“IDT&rdqu...

March 16, 2021 | Tuesday | News
Fujitsu, Kyoto University build AI system to detect genetic disorders

Fujitsu Limited and Kyoto University research group led by Professor Yasushi Okuno of the Kyoto University Graduate Scho...

March 15, 2021 | Monday | News
Takeda to acquire Maverick Therapeutics for $525 M

Japanese firm Takeda Pharmaceutical Company Limited has announced the exercise of its option to acquire Maverick Therape...

March 12, 2021 | Friday | News
Setsuro Tech gets access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-...

March 10, 2021 | Wednesday | News
Regenerative therapy to treat knee joint damages gets boost in Japan

Regenerative therapy to treat knee joint damages gets a boost with a breakthrough technology of growing ideal type of ca...

March 9, 2021 | Tuesday | News
AbbVie pips Gilead to dominate Japan’s hepatitis C virus digital marketing space

The hepatitis C virus (HCV) therapeutics market in Japan is highly competitive with stiff competition between Gilead and...

March 9, 2021 | Tuesday | News
Takeda to import & distribute Moderna’s vaccine in Japan

Moderna, Inc has announced that Takeda Pharmaceutical Co, Ltd submitted a new drug application to the Government of Japa...

March 8, 2021 | Monday | News
ERS Genomics inks licensing deal with Otsuka for CRISPR/Cas9 technology

ERS Genomics Limited, which was formed to provide broad access to foundational CRISPR/Cas9 intellectual property, has an...

March 3, 2021 | Wednesday | News
Eisai's anti-Insomnia drug Dayvigo (Lemborexant) approved in Hong Kong

Eisai Co., Ltd. announced that its Hong Kong subsidiary Eisai (Hong Kong) Co., Ltd. has obtained approval for the in-hou...

March 1, 2021 | Monday | News
Takeda transfers assets of select diabetes products to Teijin Pharma

Japanese firm Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to transfer the ...

February 26, 2021 | Friday | News
Harvard University, Kyowa Kirin collaborate for translational biomedical science

Harvard University and Kyowa Kirin Co, Ltd have announced that they have entered into a strategic research all...

March 1, 2021 | Monday | News
Olympus buys Israel's Medi-Tate to drive global urology business growth

Japan based Olympus Corporation has exercised its call option in respect of the remainder of the shares in Medi-Tate Ltd...

March 2, 2021 | Tuesday | News
Japan's Polyplastics Group expands POM material portfolio for varied medical applications

Japan's Polyplastics Group is expanding its DURACON (R) polyoxymethylene (POM) PM series portfolio with the develop...

February 26, 2021 | Friday | News
Fujitsu unveils AI-powered physical rehabilitation solution

Fujitsu has announced the launch of a new AI-powered physical rehabilitation solution in Japan, the "FUJITSU Healthcare ...

February 25, 2021 | Thursday | News